Viewing Study NCT00828958

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:04 AM
Ignite Modification Date: 2026-06-27 @ 8:54 PM
Study NCT ID: NCT00828958
Status: COMPLETED
Last Update Posted: 2011-05-18
First Post: 2009-01-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Injection Site Tolerability of Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle in Chronic Schizophrenia Patients.
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Schizophrenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None schizophrenia View
None Risperidone View
None Long acting injectable View
None Intradeltoidal injection View